These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1463 related articles for article (PubMed ID: 33975009)
1. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009 [TBL] [Abstract][Full Text] [Related]
2. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit. Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY mBio; 2020 Sep; 11(5):. PubMed ID: 32978311 [TBL] [Abstract][Full Text] [Related]
3. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567 [TBL] [Abstract][Full Text] [Related]
4. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients. Zeng F; Wu M; Wang J; Li J; Hu G; Wang L J Med Virol; 2021 Dec; 93(12):6506-6511. PubMed ID: 34170519 [TBL] [Abstract][Full Text] [Related]
5. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036 [TBL] [Abstract][Full Text] [Related]
6. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection. Yao L; Wang GL; Shen Y; Wang ZY; Zhan BD; Duan LJ; Lu B; Shi C; Gao YM; Peng HH; Wang GQ; Wang DM; Jiang MD; Cao GP; Ma MJ J Infect Dis; 2021 Aug; 224(4):586-594. PubMed ID: 33978754 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000 [TBL] [Abstract][Full Text] [Related]
8. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG. Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590 [TBL] [Abstract][Full Text] [Related]
9. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Li C; Yu D; Wu X; Liang H; Zhou Z; Xie Y; Li T; Wu J; Lu F; Feng L; Mao M; Lin L; Guo H; Yue S; Wang F; Peng Y; Hu Y; Wang Z; Yu J; Zhang Y; Lu J; Ning H; Yang H; Fu D; He Y; Zhou D; Du T; Duan K; Dong D; Deng K; Zou X; Zhang Y; Zhou R; Gao Y; Zhang X; Yang X Nat Commun; 2021 Jul; 12(1):4144. PubMed ID: 34230476 [TBL] [Abstract][Full Text] [Related]
10. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort. Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T Front Immunol; 2022; 13():817905. PubMed ID: 35185909 [TBL] [Abstract][Full Text] [Related]
11. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients. Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795 [TBL] [Abstract][Full Text] [Related]
12. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173 [TBL] [Abstract][Full Text] [Related]
13. Evolution of antibody immunity to SARS-CoV-2. Gaebler C; Wang Z; Lorenzi JCC; Muecksch F; Finkin S; Tokuyama M; Cho A; Jankovic M; Schaefer-Babajew D; Oliveira TY; Cipolla M; Viant C; Barnes CO; Bram Y; Breton G; Hägglöf T; Mendoza P; Hurley A; Turroja M; Gordon K; Millard KG; Ramos V; Schmidt F; Weisblum Y; Jha D; Tankelevich M; Martinez-Delgado G; Yee J; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Robbiani DF; Zhao Z; Gazumyan A; Schwartz RE; Hatziioannou T; Bjorkman PJ; Mehandru S; Bieniasz PD; Caskey M; Nussenzweig MC Nature; 2021 Mar; 591(7851):639-644. PubMed ID: 33461210 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604 [TBL] [Abstract][Full Text] [Related]
15. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration. Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay. Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122 [TBL] [Abstract][Full Text] [Related]
17. Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19. Aguilar-Bretones M; Westerhuis BM; Raadsen MP; de Bruin E; Chandler FD; Okba NM; Haagmans BL; Langerak T; Endeman H; van den Akker JP; Gommers DA; van Gorp EC; GeurtsvanKessel CH; de Vries RD; Fouchier RA; Rockx BH; Koopmans MP; van Nierop GP J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34499051 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity. Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752 [TBL] [Abstract][Full Text] [Related]
19. Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection. De Giorgi V; West KA; Henning AN; Chen LN; Holbrook MR; Gross R; Liang J; Postnikova E; Trenbeath J; Pogue S; Scinto T; Alter HJ; Cantilena CC J Infect Dis; 2021 Oct; 224(8):1294-1304. PubMed ID: 34089610 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike. Guthmiller JJ; Stovicek O; Wang J; Changrob S; Li L; Halfmann P; Zheng NY; Utset H; Stamper CT; Dugan HL; Miller WD; Huang M; Dai YN; Nelson CA; Hall PD; Jansen M; Shanmugarajah K; Donington JS; Krammer F; Fremont DH; Joachimiak A; Kawaoka Y; Tesic V; Madariaga ML; Wilson PC mBio; 2021 Jan; 12(1):. PubMed ID: 33468695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]